![David Westberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Westberg
Chief Executive Officer at
NANEXA AB
Profile
David Westberg is currently the Chief Executive Officer & Managing Director at Nanexa AB since 2015.
He is also a Director at W & W Management & Design AB and an Independent Director at Lipigon Pharmaceuticals AB since 2023.
Previously, he worked as the Head-Product Development Department at Pharmacia AB, a Project Manager at Orexo AB, and a Manager-Project & Operations at LIDDS AB. Mr. Westberg graduated from the Royal Institute of Technology.
David Westberg active positions
| Companies | Position | Start |
|---|---|---|
| NANEXA AB | Chief Executive Officer | 01/04/2015 |
| LIPIGON PHARMACEUTICALS AB | Director/Board Member | 01/01/2023 |
W & W Management & Design AB | Director/Board Member | - |
Former positions of David Westberg
| Companies | Position | End |
|---|---|---|
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
| OREXO AB | Corporate Officer/Principal | - |
| LIDDS AB | Chief Operating Officer | - |
Training of David Westberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Nanexa AB
 Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
W & W Management & Design AB | |
Lipigon Pharmaceuticals AB
 Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
- Stock Market
- Insiders
- David Westberg
